NASDAQ:IBRX

Immunitybio Stock Forecast

etoro logo Buy IBRX
*Your capital is at risk
$8.76
-0.0150 (-0.171%)
At Close: Jun 30, 2026
AI Analysis AI Analysis of IBRX AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add IBRX to Watchlist?
Some Reasons Why To Add IBRX:
  • +240.7% price growth over the last year
  • High gross margin of 93.8%
  • Strong return on equity of 138.7%
PDF

ImmunityBio, Inc. stock downgraded from Strong Buy Candidate to Hold/Accumulate after Tuesday trading session
(Updated on Jun 30, 2026)

Buy or Hold candidate since Jun 24, 2026 Gain 12.24%

The ImmunityBio, Inc. stock price fell by -0.171% on the last day (Tuesday, 30th Jun 2026) from $8.77 to $8.76. During the last trading day the stock fluctuated 5.08% from a day low at $8.57 to a day high of $9.00. The price has risen in 6 of the last 10 days and is up by 22.79% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -6 million shares and in total, 9 million shares were bought and sold for approximately $81.17 million.

The stock lies in the upper part of a very wide and weak rising trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at $8.77 will firstly indicate a stronger rate of rising. Given the current short-term trend, the stock is expected to rise 2.03% during the next 3 months and, with a 90% probability hold a price between $6.88 and $8.95 at the end of this 3-month period.

IBRX Signals & Forecast

The ImmunityBio, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $8.05 and $7.61. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Monday, June 29, 2026, and so far it has fallen -0.171%. Further fall is indicated until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for ImmunityBio, Inc. stock

ImmunityBio, Inc. finds support from accumulated volume at $8.71 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.435 between high and low, or 5.08%. For the last week, the stock has had daily average volatility of 8.76%.

Our recommended stop-loss: $8.44 (-3.62%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 1 day ago.)

Trading Expectations (IBRX) For The Upcoming Trading Day Of Wednesday 1st

For the upcoming trading day on Wednesday, 1st we expect ImmunityBio, Inc. to open at $8.77, and during the day (based on 14 day Average True Range), to move between $8.48 and $9.03, which gives a possible trading interval of +/-$0.541 (+/-6.38%) up or down from last closing price. If ImmunityBio, Inc. takes out the full calculated possible swing range there will be an estimated 6.38% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $8.77 (0.17%) than the support at $8.71 (0.51%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is ImmunityBio, Inc. stock A Buy?

ImmunityBio, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Strong Buy to a Hold candidate.

Current score: 0.000 Hold/Accumulate Downgraded

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Fair Opening Price

Predicted fair opening price on July 1, 2026 - $8.77 ( 0.209%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

IBRX Performance

Trading levels for IBRX

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 9.21 5.18%
R2 9.04 3.28%
R1 8.94 2.11%
Price 8.76
S1 8.61 -1.69%
S2 8.50 -2.86%
S3 8.34 -4.76%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0 -
R2 0 -
R1 8.77 0.171%
Price 8.76
S1 8.71 -0.514%
S2 7.76 -11.36%
S3 7.25 -17.19%

FAQ

What is the symbol for ImmunityBio, Inc. Stock and on which exchange is it traded?
The symbol for ImmunityBio, Inc. is IBRX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell ImmunityBio, Inc. Stock?
ImmunityBio, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Strong Buy to a Hold candidate.

How to buy ImmunityBio, Inc. Stock?
ImmunityBio, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy ImmunityBio, Inc. Stock.

What's the current price of ImmunityBio, Inc. Stock?
As of the end of day on the Jun 30, 2026, the price of an ImmunityBio, Inc. (IBRX) share was $8.76.

What is the 52-week high and low for ImmunityBio, Inc. Stock?
The 52-week high for ImmunityBio, Inc. Stock is $12.43 and the 52-week low is $1.95.

What is the market capitalization of ImmunityBio, Inc. Stock?
As of the Jun 30, 2026, the market capitalization of ImmunityBio, Inc. is 9.17B.

When is the next earnings date for ImmunityBio, Inc.?
The upcoming earnings date for ImmunityBio, Inc. is Aug 04, 2026.
Click to get the best stock tips daily for free!
ABOUT IMMUNITYBIO, INC.
ImmunityBio
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The company also develops therapeutic agents, which are in Phase II or III clinical trial for the treatment of...
GOLDEN STAR
Ticker Change Signal Date
IIIV
$20.09
5.03% Jun 25
X
XMAX
$8.34
7.31% Jun 24
NMRK
$15.02
1.60% Jun 24
JLL
$299.78
4.44% Jun 24
CAG
$13.43
4.06% Jun 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE